86 related articles for article (PubMed ID: 8723298)
1. NSAIDs may prevent colon cancer through apoptosis, not anti-inflammatory effects.
Oncology (Williston Park); 1996 Apr; 10(4):624. PubMed ID: 8723298
[No Abstract] [Full Text] [Related]
2. Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NSAIDs) alter the kinetics of human colon cancer cell lines more effectively than traditional NSAIDs: implications for colon cancer chemoprevention.
Williams JL; Borgo S; Hasan I; Castillo E; Traganos F; Rigas B
Cancer Res; 2001 Apr; 61(8):3285-9. PubMed ID: 11309281
[TBL] [Abstract][Full Text] [Related]
3. [Aspirin, non-steroidal anti-inflammatory agents and colonic carcinogenesis].
Benamouzig R; Chaussade S; Little J; Munoz N; Rautureau J; Couturier D
Gastroenterol Clin Biol; 1997; 21(3):188-96. PubMed ID: 9161493
[No Abstract] [Full Text] [Related]
4. Sulindac slows growth of colon polyps, may prevent colon cancer.
Oncology (Williston Park); 1996 Feb; 10(2):218. PubMed ID: 8838263
[No Abstract] [Full Text] [Related]
5. TNF-related apoptosis-inducing ligand cooperates with NSAIDs via activated Wnt signalling in (pre)malignant colon cells.
Heijink DM; Jalving M; Oosterhuis D; Sloots IA; Koster R; Hollema H; Kleibeuker JH; Koornstra JJ; de Vries EG; de Jong S
J Pathol; 2011 Feb; 223(3):378-89. PubMed ID: 21171083
[TBL] [Abstract][Full Text] [Related]
6. The NSAID sulindac is chemopreventive in the mouse distal colon but carcinogenic in the proximal colon.
Mladenova D; Daniel JJ; Dahlstrom JE; Bean E; Gupta R; Pickford R; Currey N; Musgrove EA; Kohonen-Corish MR
Gut; 2011 Mar; 60(3):350-60. PubMed ID: 20980345
[TBL] [Abstract][Full Text] [Related]
7. Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion.
Samaha HS; Kelloff GJ; Steele V; Rao CV; Reddy BS
Cancer Res; 1997 Apr; 57(7):1301-5. PubMed ID: 9102217
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention by nonsteroidal anti-inflammatory drugs eliminates oncogenic intestinal stem cells via SMAC-dependent apoptosis.
Qiu W; Wang X; Leibowitz B; Liu H; Barker N; Okada H; Oue N; Yasui W; Clevers H; Schoen RE; Yu J; Zhang L
Proc Natl Acad Sci U S A; 2010 Nov; 107(46):20027-32. PubMed ID: 21041628
[TBL] [Abstract][Full Text] [Related]
9. Role of Sulindac and Celecoxib in chemoprevention of colorectal cancer via intrinsic pathway of apoptosis: exploring NHE-1, intracellular calcium homeostasis and Calpain 9.
Vaish V; Sanyal SN
Biomed Pharmacother; 2012 Mar; 66(2):116-30. PubMed ID: 22390894
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of sulindac hydroxamic acid against human pancreatic and colonic cancer cells.
Fogli S; Banti I; Stefanelli F; Picchianti L; Digiacomo M; Macchia M; Breschi MC; Lapucci A
Eur J Med Chem; 2010 Nov; 45(11):5100-7. PubMed ID: 20801552
[TBL] [Abstract][Full Text] [Related]
11. Comparing the effects of COX and non-COX-inhibiting NSAIDs on enhancement of apoptosis and inhibition of aberrant crypt foci formation in a rat colorectal cancer model.
Martin JE; Young GP; LE Leu RK; Hu Y
Anticancer Res; 2013 Sep; 33(9):3581-8. PubMed ID: 24023283
[TBL] [Abstract][Full Text] [Related]
12. Sulindac in familial adenomatous polyposis.
Levy R
N Engl J Med; 2002 Aug; 347(8):615. PubMed ID: 12192027
[No Abstract] [Full Text] [Related]
13. Influence of K-ras activation on the survival responses of Caco-2 cells to the chemopreventive agents sulindac and difluoromethylornithine.
Lawson KR; Ignatenko NA; Piazza GA; Cui H; Gerner EW
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1155-62. PubMed ID: 11097222
[TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer--chemoprevention.
Boone WT
J Miss State Med Assoc; 1998 Sep; 39(9):318-22. PubMed ID: 9757628
[TBL] [Abstract][Full Text] [Related]
15. Sulindac and exisulind exhibit a significant antiproliferative effect and induce apoptosis in human hepatocellular carcinoma cell lines.
Rahman MA; Dhar DK; Masunaga R; Yamanoi A; Kohno H; Nagasue N
Cancer Res; 2000 Apr; 60(8):2085-9. PubMed ID: 10786664
[TBL] [Abstract][Full Text] [Related]
16. Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis.
Chiu CH; McEntee MF; Whelan J
Cancer Res; 1997 Oct; 57(19):4267-73. PubMed ID: 9331087
[TBL] [Abstract][Full Text] [Related]
17. Antiproliferative effects of nitrosulindac on human colon adenocarcinoma cell lines.
Lavagna C; Burgaud JL; Del Soldato P; Rampal P
Biochem Biophys Res Commun; 2001 Jun; 284(3):808-16. PubMed ID: 11396974
[TBL] [Abstract][Full Text] [Related]
18. Sulindac and its derivatives: a novel class of anticancer agents.
Haanen C
Curr Opin Investig Drugs; 2001 May; 2(5):677-83. PubMed ID: 11569947
[TBL] [Abstract][Full Text] [Related]
19. Drugs to prevent colon cancer show promise, but hurdles remain for chemoprevention.
Tuma R
J Natl Cancer Inst; 2008 Jun; 100(11):764-6. PubMed ID: 18505958
[No Abstract] [Full Text] [Related]
20. Aspirin and colon cancer.
Goldberg Y
N Engl J Med; 1996 Mar; 334(12):800-1. PubMed ID: 8592564
[No Abstract] [Full Text] [Related]
[Next] [New Search]
